Skip to main content
. 2020 Dec 7;8:558375. doi: 10.3389/fbioe.2020.558375

TABLE 1.

Classification and major features of stem cells reported in glioma therapy.

Stem cell Defining criteria Source/Niche Linage
Pluripotent stem cells: capacity to differentiate into any cell of all three germ layers

Embryonic stem cells (ECSs) Markers of pluripotency as found in ICM cells:
Transcription factors: Oct4, Nanog, Rex-1
Cell surface markers: SSEA-3, SSE-A4, TRA-1-60, TRA-1-81, alkaline phosphatase
Blastocyst Morula Growth-arrested embryos Somatic cell nuclear transfer Single blastomere As defined by pluripotency
Induce pluripotent stem cells (iPSCs) Essentially the same than ECS markers Reprogrammed adult somatic cells—usually fibroblasts or skin cells. As defined by pluripotency given than iPSC are functionally equivalent to ECS

Multipotent stem cells: capacity to differentiate into cells of one of the three germ layers

Neural stem cells (NSCs) Positive: GFAP, CD133, CD184, and Nestin, Sox1, Sox2, and Pax6
Negative: CD271, CD44, CD24
Immune profile: Absent HLA II
Subependymal zone (SEZ)—lining the lateral ventricles Dentate gyrus of the hippocampus *Obtained from fetal and adult mammals Neurons Oligodendrocytes Astrocytes Ependymal cells
Mesenchymal stem cells (MSCs) MSC must comply with ISCT criteria:
Positive (>95% +): CD105, CD73, CD90
Negative (<2% –): CD45, CD34, CD14 or CD11b, CD79α, or CD19, HLA DR Adherence to plastic in standard culture conditions In vitro differentiation to osteoblast, adipocytes, and chondroblasts.
Immune profile: Absent HLA II
Adult tissues: adipose tissue, bone marrow, peripheral blood, dental pulp, ligamentum flavum, synovium, endometrium, sweat glands, and milk
Fetal tissues: umbilical cord, umbilical cord blood, Wharton jelly, amniotic fluid, chorionic villi, and placenta
Osteoblast Adipocytes Chondroblast *Differentiation into ectodermal and endodermal linages has also been reported
Hematopoietic stem cells (HMSs) Negative: CD45R/B220 (B cells), Gr-1 (granulocytes), Mac-1 (macrophages), Ter-119 (erythrocytes) and CD4/CD8 (lymphocytes)—for phenotypic enrichment.
Positive: Sca-1, c-Kit, CD150 *They appear as side population in dye exclusion assays due to the high expression of MDR pumps
Adult tissues: bone marrow, peripheral blood
Non-adult tissues: umbilical cord blood, yolk sac, liver, spleen
Hematopoietic cells

IMC, inner mass cells; MDR, multidrug resistance.